The invention is concerned with novel indazole derivatives of formula (I)
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPT1 and can be used in the prevention or treatment of diseases which are modulated by L-CPT1 inhibitors.